Daniel Amoako-Sakyi
Overview
Explore the profile of Daniel Amoako-Sakyi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barnes P, Mensah A, Derkyi-Kwarteng L, Adankwa E, Agbo E, Yahaya E, et al.
Med Princ Pract
. 2024 May;
:1-11.
PMID: 38723618
Breast cancer is the most prevalent cancer among African women, with high mortality rates in Ghana. Nuclear factor kappa B (NF-kB) has been associated with tumor progression in breast cancer....
2.
DAtanasio E, Risi F, Ravasini F, Montinaro F, Hajiesmaeil M, Bonucci B, et al.
Curr Biol
. 2023 Nov;
33(24):5495-5504.e4.
PMID: 37995693
The population history of the Sahara/Sahelian belt is understudied, despite previous work highlighting complex dynamics. The Sahelian Fulani, i.e., the largest nomadic pastoral population in the world, represent an interesting...
3.
Osman A, Amoako Johnson F, Mariwah S, Amoako-Sakyi D, Owusu S, Ekor M, et al.
BMJ Glob Health
. 2023 Sep;
6(Suppl 3).
PMID: 37734858
Global health efforts such as malarial control require efficient pharmaceutical supply chains to ensure effective delivery of quality-assured medicines to those who need them. However, very little is currently known...
4.
Amoako-Sakyi D, Obiri-Yeboah D, Ofosu A, Kusi K, Osei K, Adade R, et al.
BMC Public Health
. 2022 Oct;
22(1):1899.
PMID: 36224589
Background: Vaccine-preventable diseases (VPDs) persist globally with a disproportionately high burden in Low and Middle-Income Countries (LMICs). Although this might be partly due to the failure to sustain vaccination coverage...
5.
Hampshire K, Mariwah S, Amoako-Sakyi D, Hamill H
Glob Bioeth
. 2022 Aug;
33(1):103-121.
PMID: 35912379
The governance of pharmaceutical medicines entails complex ethical decisions that should, in theory, be the responsibility of democratically accountable government agencies. However, in many Low- and Middle-Income Countries (LMICs), regulatory...
6.
Kusi K, Aggor F, Amoah L, Anum D, Nartey Y, Amoako-Sakyi D, et al.
PLoS One
. 2020 Feb;
15(2):e0228177.
PMID: 32040522
Background: Sterile protection against malaria, most likely mediated by parasite-specific CD8+ T cells, has been achieved by attenuated sporozoite vaccination of animals as well as malaria-naïve and malaria-exposed subjects. The...
7.
Obiri-Yeboah D, Awuku Y, Adjei G, Cudjoe O, Hayfron Benjamin A, Obboh E, et al.
PLoS One
. 2019 Jun;
14(6):e0219148.
PMID: 31251790
Background: HBV vaccine is known to offer protection against transmission of HBV infection. Health care workers are mandated to have this vaccination as part of their occupational health safety measures....
8.
Hamill H, Hampshire K, Mariwah S, Amoako-Sakyi D, Kyei A, Castelli M
Soc Sci Med
. 2019 Jun;
234:112369.
PMID: 31238286
Where regulation is weak, medicine transactions can be characterised by uncertainty over the drug quality and efficacy, with buyers shouldering the greater burden of risk in exchanges that are typically...
9.
Obiri-Yeboah D, Awuku Y, Adu J, Pappoe F, Obboh E, Nsiah P, et al.
PLoS One
. 2018 Jan;
13(1):e0191685.
PMID: 29370271
Background: Hepatitis E virus is an emerging infection in Africa with poor maternal and foetal outcomes. There is scanty data on the sero-prevalence of HEV infection among pregnant women in...
10.
Obiri-Yeboah D, Akakpo P, Mutocheluh M, Adjei-Danso E, Allornuvor G, Amoako-Sakyi D, et al.
BMC Cancer
. 2017 Oct;
17(1):688.
PMID: 29037188
Background: There is limited data in Ghana on the epidemiology of HPV and cervical neoplasia and their associations with HIV. This study aimed to compare among HIV-1 seropositive and HIV-seronegative...